Response to: Amantadine, COVID-19 and Parkinsonism

Arch Med Res. 2020 Oct;51(7):715. doi: 10.1016/j.arcmed.2020.07.002. Epub 2020 Jul 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amantadine / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Parkinsonian Disorders* / drug therapy
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Amantadine